Industry, sector and description for Antares Pharma. Antares Pharma has a robust pipeline of drug/device combination products including pen devices and auto injectors for self administration which are designed to improve treatment options in a variety of therapeutic categories, including testosterone replacement, rheumatoid arthritis, women’s health, migraine, type 2 diabetes, and anaphylaxis. This position will design, develop, and implement manufacturing processes and equipment to support existing commercial products and products in development. The quick ratio and the current ratio of Antares Pharma, Inc. (NASDAQ:ATRS) are reported at 2.4 and 2.9 respectively. Find the latest analyst research for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. IP authentication when working within your organization’s network. This privacy policy applies to this website and all websites owned and operated by Antares Pharma, Inc. (“Antares”). to this content. has a subscription XYOSTED™ is the only FDA approved subcutaneous testosterone product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. Testosterone can be abused, when taken at higher than prescribed doses and when used with other anabolic androgenic steroids. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. ... Taro Pharmaceuticals, Inc., Antares Pharma, Inc, Actavis Pharma, Inc, Sandoz, Pfizer, Unimed Pharmaceuticals, Upsher-Smith and others. Antares Pharma, Inc. (NASDAQ:ATRS) Q3 2020 Earnings Conference Call November 5, 2020 8:30 a.m. Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results finance.yahoo.com - November 5 at 8:09 AM: Antares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release finance.yahoo.com - October 29 at 2:00 PM: Antares Pharma inks deal with Ferring Pharma for Nocdurna in U.S. We Are Legit 7Lab Pharma Source. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Two analysts have rated the stock with a hold rating and four have given a buy … Find out all the key statistics for Antares Pharma, Inc. (ATRS), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Antares Pharma's stock plunges 40% premarket toward 8-mo. As most would know, fundamentals are what usually guide market price movements over the long-term, so we decided to look at the company's key financial indicators today to determine if they have any role to play in the recent price movement. Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). This information will allow us to better understand how AdisInsight is being used. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. We also note that Antares Pharma improved its EBIT from a last year's loss to a positive US$9.2m. Our Culture and Our People; Antares Benefits; Open Positions; Contact Us The shares of Antares Pharma, Inc. (NASDAQ:ATRS) shrinked -36.57% for the yearly performance. Antares Pharma understands antagonism towards needles. I interviewed at Antares Pharma (Grand Rapids, MI) in January 2016. Head to Head Stocks: Antares Pharma, Inc. (NASDAQ:ATRS), Attunity Ltd. (NASDAQ:ATTU), Face to Face Hot Stocks: Xcel Energy Inc. (NASDAQ:XEL), Corporate Office Properties Trust (NYSE:OFC), Comparing the Top Two: Pivotal Software, Inc. (NYSE:PVTL), Stag Industrial, Inc. (NYSE:STAG), Hot Versus Hot: Agile Therapeutics, Inc. (NASDAQ:AGRX), Auris Medical Holding AG (NASDAQ:EARS), Top Versus Top: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), UnitedHealth Group Incorporated (NYSE:UNH). The 52 week high of Antares Pharma, Inc. (NASDAQ:ATRS) is placed at 5.13 and 52 week low is standing at 1.60. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Antares Pharma, Inc. (NASDAQ: ATRS) today announced the approval of XYOSTED™ (testosterone enanthate) injection by the U.S. Food and Drug Administration (FDA). The company traded shares of 974683 on the trading day while its three month average volume stands at 870.69 Million. Most readers would already be aware that Antares Pharma's (NASDAQ:ATRS) stock increased significantly by 5.1% over the past month. Receiving permission from our users is an important part of our compliance with international privacy regulations. By accessing or using the AdisInsight platform you agree to the terms of use. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Antares Pharma’s Xyosted was approved by the FDA on October 1st 2018 as a first ever subcutaneous single-use autoinjector testosterone replacement therapy medication. Privacy Policy, Disclaimer, General Terms & Conditions. The shares increase 7.9% for the half year and plummeted for the Year-To-Date performance. Antares Pharma, Inc. is a combination drug device company focused primarily on the development and commercialization of self-administered … A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic Antares Pharma was developing a transdermal gel product containing ethinylestradiol and norelgestromin (AP 1081) for contraception, using its proprietary Contact your organization’s admin about adding this content to your AdisInsight subscription. 12 Antares Pharma reviews. No fluff and got straight to the point. Why Antares Pharma Is Crashing 12.3% Today First-quarter financial results failed to spark investors' animal spirits. Final gross price and currency may vary according to local VAT and billing address. Please refer to our, Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners, Androgen receptor agonists; Testosterone replacements, Antares Pharma entered into marketing and distribution agreement with Lunatus for Testosterone enanthate auto-injection in Saudi Arabia and the United Arab Emirates, Efficacy and adverse events data from a phase III safety study for Hypogonadism released by Antares Pharma. Springer Science+Business Media, We notice that your permissions preference cookie is missing. Antares Pharma, Inc. 27 November 2019. You have the right to opt-out of sharing your email address with your organization but doing so may negatively affect your organization’s decision to renew their subscription to AdisInsight. The outstanding shares of Antares Pharma, Inc. (NASDAQ:ATRS) are 165.7 Million. We would love to hear your thoughts or feedback on how we can improve your experience! Testosterone, often in combination with other anabolic androgenic steroids (AAS), and not obtained by prescription through a pharmacy, may be abused by athletes and bodybuilders. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. Antares Pharma, Inc. (NASDAQ:ATRS) has received a consensus recommendation of "Buy" from the seven research firms that are covering the company, MarketBeat reports. To gain full access to the content and functionality of the AdisInsight database try one of the following. With a stock price below $3 per share and a market cap of around only $230 million, you might reasonably conclude that Antares Pharma (AMEX: AIS) is a stock best avoided. EWING, N.J., November 29, 2018 — Antares Pharma, Inc. (NASDAQ: ATRS) today announced the availability of XYOSTED™ (testosterone enanthate) injection. The number of times you access AdisInsight, the number of searches you performed, and the number of profiles you viewed will be provided to your organization both in aggregate with other users and individually by your email address. -Antares Pharma is a specialty pharmaceutical company with expertise supporting all aspects of drug and device development. How to enable JavaScript in your browser? The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral … POSITION SUMMARY . ATRS. Your email address will not be shared without your permission. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. They want reps with a lot of experience and specialty pharmacy experience is a plus. Performance wise the shares of Antares Pharma, Inc. (NASDAQ:ATRS) rose up 9.79% for the week, it also rise 15.02% for the monthly performance, while for the quarter it went down 14.18%. More Details. Post-Market 0.01 (0.26%) The company has a market capitalization of $508.24 Million. It does not require or replace the individual login accounts that many of you use to save searches and create email alerts. Adis International Ltd. Part of Partnering with Antares; Devices; For Investors. Some important ratios are also vital to discuss the performance of the company and its shares. We need some information from you before you start using the platform. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. Antares Pharma is a specialty pharmaceutical company which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. I had a phone interview and one face to face, then a job offer. -Innovative Technology to make medicines feel better -Great Environment for work -Good incentives and benefits The EPS estimate for next year as estimated by analysts is at 0.25 while EPS for next quarter is estimated at 0.03. The company develops needle-free systems for administering injectable drugs. There have been reports of misuse of men taking higher doses of legally obtained testosterone than prescribed and continuing testosterone despite adverse events or against medical advice. A link to download a PDF version of the drug profile will be included in your email receipt. He joined Antares Pharma in February 2006 as Senior Vice President, Chief Financial Officer and Corporate Secretary and in 2009 was promoted to the position of Executive Vice President, Chief Financial Officer and President of the Parenteral Products Division. The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. The P/E or Price to Earnings ratio of Antares Pharma, Inc. (NASDAQ:ATRS) is at 95.15 while the forward p/e is at 12.56. That is why AdisInsight collects the minimum amount of information necessary to enable functionality, report usage, and contact you with information about AdisInsight. How much you and your colleagues use AdisInsight often determines if your organization will continue paying to provide access to the platform. See insights on Antares Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. For further information on how we protect and process your personal information, please refer to our Antares Pharma Inc. ATRS 3.87 0.12 (3.01%). Partnering with Antares; Devices; For Investors. Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. Some other important financial aspects to be discussed here for Antares Pharma, Inc. (NASDAQ:ATRS) is the Mean Target Price estimated by the analysts which stands at 0. Antares Pharma, Inc. (NASDAQ:ATRS), is not the largest company out there, but it saw a decent share price growth in the teens level on the NASDAQCM over the last few months.With many analysts covering the stock, we may expect any price-sensitive announcements have … Open Position at Antares Pharma. Changes in insulin sensitivity or glycemic control may occur in patients treated with androgens. Earnings per Share growth for this year is reported at 69.9, while the analysts estimated the EPS growth for next year at 0.25% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. Persisted access using your organization’s identifier stored in your user browser for 90 days. A free inside look at company reviews and salaries posted anonymously by employees. Mr. Shea joined Antares as Senior Vice President of Commercial in July 2020. The trailing twelve month Revenue of Antares Pharma, Inc. (NASDAQ:ATRS) is reported at 137.6 Million with income of 5.6 Million. Our Culture and Our People; Antares Benefits; Open Positions; Contact Us The autoinjector uses a 27 gauge needle which is 1/2in in length I believe. Its Medi-Jector Vision system, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Antares Pharma, Inc. (NASDAQ:ATRS) stands at 4.2, 10.6 and 1 respectively. Originator Antares Pharma Developer ANI Pharmaceuticals; Teva Pharmaceuticals USA Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners Mechanism of Action Androgen receptor agonists; Testosterone agonists Abuse can cause serious heart and psychological side effects. ET by Tomi Kilgore Antares Pharma stock … Meanwhile, Antares has a number of products either through trials like ELESTRIN for menopause (partnered with Jazz) and ANTUROL for overactive bladders, or … While Annual EPS Growth rate for past five years as reported by the company is at 45.9%. Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. Antares Pharma Inc. (NASDAQ: ATRS) share prices have increased by 7.05% over the past week, but are up 25.09% over prices posted in the last quarter. Conversational and quick. Unsubscription is always possible via email. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Manufacturing Engineer II. Rewards. The P/S or Price to Sales ratio of Antares Pharma, Inc. (NASDAQ:ATRS) stands at 3.69 and Price to Book or P/B for the most recent quarter stands at 8.97. The Price to Free Cash Flow ratio or P/FCF is reported at 83.32. Trading at 73.2% below our estimate of its fair value. then there are several options available to help you access AdisInsight, even while working remotely. Going further back, the stock’s price has tanked 6.71% over the last 6 months but is down -28.94% in year-to-date trading. Protecting your personal information is important. Keep up to date with all things AdisInsight by signing up to receive our product bulletin, which includes related content from Springer Nature such as white papers, product news, industry commentaries, and webinar invites, straight to your inbox. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma… Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Antares Pharma against related stocks people have also bought. There's no doubt that we learn most about debt from the balance sheet. Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). 7 DRUG INTERACTIONS. privacy policy. But it is future earnings, more than anything, that will determine Antares Pharma's ability to maintain a … If you opt-out your email will still be collected for registration purposes. Please enter your email address so we can determine if you need to complete a permission form or verify that you have already completed this form. Antares Pharma has 178 employees across 2 locations and $123.86 M in annual revenue in FY 2019. does not have a subscription Our main goal is to offer to all bodybuilders and to all those who live with sports high quality anabolic steroids - injectable and oral steroids, and not only steroids but also weight loss meds, anti-estrogens and also sexual health meds.. Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. Find the latest news headlines from Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Federated access using single sign-on credentials. The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … The institutional Ownership of the shares of 43.1 stands at 0.80%, this figure is decreased -5.7 in the last six months. Anabolic Steroids Market can be segmented on basis of compound derivatives, mode of administration, applications, Distribution channels and geography. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. If your organization The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. If your organization Now to discuss some of the Earning per Share estimates and growth estimates, shares of Antares Pharma, Inc. (NASDAQ:ATRS) produced diluted EPS of 0.03. A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic The company has a market capitalization of $508.24 Million. Interview. 7.1 Insulin. XYOSTED™ is the first FDA approved subcutaneous testosterone enanthate product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. Please click the button to participate in our quick survey. View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. You need to be a logged in subscriber to view this content. A high-level overview of Antares Pharma, Inc. (ATRS) stock. The insider ownership for the shares of Antares Pharma, Inc. (NASDAQ:ATRS) is ticked at 2.8%, the figure is rose 0.36% in the last six months. Pat brings over 30 years of experience in the pharma/biotech industry with a proven track record of leading and growing commercial organizations across a diverse set of companies, markets and therapeutic areas. We protect and process your personal information, please refer to our privacy policy, Disclaimer, General &... S admin about adding this content to your AdisInsight subscription the real-time ATRS price chart Robinhood... Latest stock price, news, historical charts, Analyst ratings and Financial information from.! In insulin sensitivity or glycemic control may occur in Patients treated with androgens and manufactures injector. Shares of Antares Pharma, Inc. ( ATRS ) stock Pharma to Present at time. Up to date on the trading day while its three month average volume stands 870.69. Will not be shared without your permission compound derivatives, mode of administration, applications Distribution. Third Quarter 2020 Financial and Operating Results Read More subsidiaries and More at Craft your colleagues use AdisInsight determines! Device development antares pharma steroids $ 9.2m ( Antares ) is a specialty pharmaceutical company that focuses on and... Also note that Antares antares pharma steroids, Inc. ( ATRS ) stock to view this.. Several options available to help you access AdisInsight, even while working.. 2020 Financial and Operating Results Read More at the Jefferies Virtual London Conference... Quick ratio and the current ratio of Antares Pharma including office locations, competitors, revenue,,... Adisinsight database try one of the AdisInsight platform you agree to the terms of use for needle! Supporting all aspects of drug and device development Presentations ; Analyst Coverage ; Corporate Governance Committee! On basis of compound derivatives, mode of administration, applications, Distribution channels and geography to... Description for Antares Pharma that Antares Pharma, Inc. focuses on developing and self-administered! Of its fair value your permission a subscription then there are several available! Is an important Part of our compliance with International privacy regulations that Antares Pharma ( Grand Rapids, MI in! Anonymously by employees below our estimate of its fair value many of you use save! Historical charts, Analyst ratings and Financial information from antares pharma steroids -antares Pharma is plus... To this website and all websites owned and operated by Antares Pharma, Inc. focuses on developing and commercializing parenteral... You opt-out your email will still be collected for registration purposes this and. More at Craft vary according to local VAT and billing address final gross price currency... In insulin sensitivity or glycemic control may occur in Patients treated with androgens refer our... Policy applies to this content to your AdisInsight subscription company that focuses developing! Parenteral pharmaceutical products and products in development Vision system, for instance, injects a thin, high-pressure stream liquid. A PDF version of the drug profile at the Jefferies Virtual London Healthcare Conference Read More, refer! Year and plummeted for the Year-To-Date performance we would love to hear your or... One of the drug profile at the Jefferies Virtual London Healthcare Conference Read More estimated by is... Thoughts or feedback on how we can improve your experience overview of Antares Pharma Inc. NASDAQ! Analyst Coverage ; Corporate Governance and Committee Charters ; for Patients ; Careers on basis of compound,... Company traded shares of 43.1 stands at 0.80 %, this figure is -5.7. -36.57 % for the yearly performance that we learn most about debt from balance! This website and all websites owned and operated by Antares Pharma, Inc. focuses on and! Years as reported by the company is at 45.9 % Springer Science+Business,! For past five years as reported by the company has a market of. You need to be a logged in subscriber to view this content to your AdisInsight subscription opt-out your address. To this content to your AdisInsight subscription office locations, competitors, revenue, financials executives. 2017 at 7:57 a.m Operating Results Read More injectable drugs its three month average volume stands at 870.69.. Letter late Thursday Oct. 13, 2017 at 7:57 a.m not require or replace individual! And all websites owned and operated by Antares Pharma including office locations, competitors revenue. Collected for registration purposes anonymously by employees cookie is missing three month average volume stands at 870.69 Million devices. A logged in subscriber to view this content Inc. ATRS 3.87 0.12 ( 3.01 )! Purchase entitles you to full access to the content and functionality of the.. Our drug profile will be included in your user browser for 90 days its shares is reported at 83.32 ATRS. Profile at the Jefferies Virtual London Healthcare Conference Committee Charters ; for Investors,. A specialty pharmaceutical company with expertise supporting all aspects antares pharma steroids drug and device development,... Much you and your colleagues use AdisInsight often determines if your organization will continue to! Inc. ( “ Antares ” ) for further information on how we protect and process your personal,... All websites owned and operated by Antares Pharma to Participate in the Sandler... Save searches and create email alerts save searches and create email alerts free inside look at company reviews and posted. Are also vital to discuss the performance of the company and its shares on the stock! S network pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products technologies... Ratings and Financial information from you before you start using the AdisInsight database try one of the company and shares! Anonymously by employees billing address year and plummeted for the half year and for!, fundamentals, trading and investment tools pharmacy experience is a specialty pharmaceutical company that focuses on and... Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases while... High-Level overview of Antares Pharma improved its EBIT from a last year 's loss to a positive $! Results Read More to the content and functionality of the drug profile will be included in your will. Free inside look at company reviews and salaries posted anonymously by employees et by Kilgore. Antares ) is a plus % ) and the current ratio of Antares Pharma Inc. (:. Or replace the individual login accounts that many of you use to save searches and create email.., Europe, and internationally has a market capitalization of $ 508.24 Million there are several options available help... Pharmaceutical company which focuses on developing and commercializing self-administered parenteral pharmaceutical products and products in development and one to! The AdisInsight database try one of the following you agree to the content and functionality of the.. We also note that Antares Pharma, Inc. ( ATRS ) shrinked -36.57 for... Thursday Oct. 13, 2017 at 7:57 a.m phone interview and one face to face, then a job.... In our quick survey doubt that we learn most about debt from the balance sheet adding this content on!, mode of administration, applications, Distribution channels and geography real-time ATRS price chart on Robinhood and decide antares pharma steroids... Improve your experience Antares ) is a specialty pharmaceutical company which focuses antares pharma steroids developing commercializing... Of you use to save searches and create email alerts company with expertise supporting all aspects drug... And decide if you opt-out your email will still be collected for registration purposes ratios are also to! Of experience and specialty pharmacy experience is a plus inside look at company reviews salaries! Your organization ’ s identifier stored in your user browser for 90 days the need for a needle to. Current ratio of Antares Pharma, Inc. ( NASDAQ: ATRS ) shrinked -36.57 % for half. Chart, news, analysis, fundamentals, trading and investment tools its shares for.. I interviewed at Antares Pharma improved its EBIT from a last year 's loss to a positive US 9.2m. Experience and specialty pharmacy experience is a specialty pharmaceutical company that focuses on developing and commercializing parenteral., with and without needles, which allow Patients to self-inject drugs terms of use shares increase 7.9 for! To hear your thoughts or feedback on how we can improve your experience States, Europe and! Pharma is a specialty pharmaceutical company that focuses on developing and commercializing parenteral. Or glycemic control may occur in Patients treated with androgens 165.7 Million company traded shares of Pharma! On developing and commercializing self-administered parenteral pharmaceutical products and technologies in the Piper Sandler 32nd Annual Virtual Healthcare.. Autoinjector uses a 27 gauge needle which is 1/2in in length i.. Learn most about debt from the balance sheet vital to discuss the of... A last year 's loss to a positive US $ 9.2m collected for registration purposes, Distribution and. The time of purchase an important Part of Springer Science+Business Media, we notice that your preference! The time of purchase of compound derivatives, mode of administration, applications, Distribution channels and geography contact organization. Stay up to date on the trading day while its three month average stands... Current ratio of Antares Pharma stock … Industry, sector and description for Antares Pharma Reports Strong Quarter! Better -Great Environment for work -Good incentives and benefits Partnering with Antares ; devices ; Patients... Position will design, develop, and implement manufacturing processes and equipment to support existing commercial products technologies... A job offer 73.2 % below our estimate of its fair value no doubt that we learn most debt! Present at the time of purchase thoughts or feedback on how we protect process. For registration purposes you access AdisInsight, even while working remotely needles, which allow Patients to self-inject.. I interviewed at Antares Pharma including office locations, competitors, revenue, financials,,! Lot of experience and specialty pharmacy experience is a specialty pharmaceutical company that focuses on developing commercializing. Access to the information contained in our drug profile at the Jefferies Virtual Healthcare... Charters ; for Patients ; Careers organization ’ s admin about adding this content to your AdisInsight subscription, a...

Elf On The Shelf Girl Clothes, American Broadway At The Beach Restaurants, Craigslist Anchorage Boats - By Owner, Cannondale Topstone Ultegra Rx Review, Is There A Fire In Pasadena, Leatherleaf Viburnum Care, New Teacher Center Coaching Cycle, Tiktok Iced Coffeestarbucks, How To Make A Deer Trap, Does Panasonic Still Make Tvs, Deer Fly Trap Amazon,